CI_with has_Ingredient has_MoA has_PE may_diagnose may_prevent may_treat drug associated with AE in adult drug associated with AE in pediatric used to treat disease Lipoxygenase Inhibitors [MoA] Glucocorticoid Receptor Agonists [MoA] Addison Disease [Disease/Finding] Asthma [Disease/Finding] Brain Edema [Disease/Finding] Cushing Syndrome [Disease/Finding] Depressive Disorder [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Hematologic Diseases [Disease/Finding] Nasal Polyps [Disease/Finding] Nausea [Disease/Finding] Neoplasms [Disease/Finding] Rhinitis, Allergic, Perennial [Disease/Finding] Shock, Septic [Disease/Finding] Tuberculosis, Ocular [Disease/Finding] Vomiting [Disease/Finding] Eye Infections, Fungal [Disease/Finding] Eye Infections, Viral [Disease/Finding] Dexamethasone [Chemical/Ingredient] Carbohydrate Metabolism Alteration [PE] Decreased Adhesion Factor Activity [PE] Decreased Complement Production [PE] Decreased Glucocorticoid Secretion [PE] Decreased Histamine Activity [PE] Decreased Intravascular Volume [PE] Decreased Kinin Activity [PE] Decreased Leukotriene Activity [PE] Decreased Lysosomal Function [PE] Decreased Myeloid Cell Production [PE] Decreased Prostaglandin Activity [PE] Decreased Protein Synthesis [PE] Decreased Thromboxane Activity [PE] Lipid Metabolism Alteration [PE] Decreased Polymorphonuclear Leukocyte Migration [PE] Decreased Fibroblast Migration [PE] Decreased Capillary Permeability [PE] D [Preparations] DEXAMETHASONE http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/11664slr062_decadron_lbl.pdf N0000146273 DEXAMETHASONE Dexamethasone <VANDF_Record>50.6^270^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>270</VA_IEN> Active C13562 <VANDF_Record>50.416^517^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>517</VA_IEN> 7S5I7G3JQL Ingredient 4017922 3264 C0011777 allergic hypersensitivity disease bradycardia AE acne AE anaphylactoid reaction AE cardiac arrest angioedema AE cardiac failure AE anaphylaxis AE